by Ryan O’byrne, University of Alberta FIG 1 The massive elevation of plasma Gal-9 discriminates COVID-19 patients from healthy subjects. (A) Detected concentrations of Gal-9 in the plasma specimens of COVID-19-infected individuals compared to healthy controls (HCs) as measured by ELISA. (B) Detected plasma levels of Gal-9 in COVID-19 patients with mild/moderate or severe disease versus...
UNIVERSITY OF MINNESOTA MEDICAL SCHOOL MINNEAPOLIS/ST. PAUL (06/08/2021) — New research from the University of Minnesota Medical School and colleagues at the Mayo Clinic reveals a possible new approach to preventing death and severe disease in elderly people infected with SARS-CoV-2. The researchers demonstrated in a preclinical study that senolytic drugs significantly reduced mortality upon infection from...
AUTHOR Ben Fidler@BentheFidler PUBLISHED Feb. 11, 2021 Dive Brief: An anti-inflammatory drug from Roche cut the risk of death in patients hospitalized with severe COVID-19, investigators in a massive British trial known as RECOVERY reported Thursday, a definitive finding that could change how patients with the disease are treated. Treatment with the drug, which Roche sells as...
by NYU Langone Health Functional magnetic resonance imaging (fMRI) and other brain imaging technologies allow for the study of differences in brain activity in people diagnosed with schizophrenia. The image shows two levels of the brain, with areas that were more active in healthy controls than in schizophrenia patients shown in orange, during an fMRI study...
